Tim is an experienced biotech and pharmaceutical leader with a strong track record in executive (Exec Chair, CEO, CBO) and board roles. A founder with over 40 patents and publications, he has successfully led companies through key growth phases, securing over $6 billion in deals, including M&A, licensing, and collaborations. His expertise spans drug discovery, business development, fundraising, and strategic advisory across oncology, CNS, cardiometabolic, AI/ML, inflammation, and vaccines. Tim is known for pioneering innovative R&D approaches and building high-performing cross-functional teams to drive biotech success.